Senator Elizabeth Warren has urged the U.S. Federal Trade Commission to review CVS Health’s $9.5-billion acquisition of Oak Street Health Inc as well as other merger deals in the sector, according to Reuters. The Oak Street deal was CVS’ third largest deal in the last decade and follows similar moves by rivals Walgreens Boots Alliance, Cigna Corp and UnitedHealth Group as the focus on primary and urgent care delivery has increased since the COVID-19 pandemic. Warren warned that consolidation may not lead to promised benefits, the report said. Read more.
US Senator Warren Urges FTC to Review CVS-Oak Street Deals
